is glp 1 patches safe to use GLP-1 Patches: Are They Really Effective for Weight Loss? GLP-1 Patches vs. GLP-1 Injections:

Separate estimates suggest around 10 million Americans were on GLP-1 treatment in 2025, with JP Morgan projecting 25 million by 2030

Although periconceptional exposure to GLP-1 receptor agonists has not shown an increased risk of malformations, data on complications such as fetal growth restriction or embryonic death are lacking [188]

The category-level data tells the real story

No great, actually

92 Luseogliflozin is a selective SGLT-2 inhibitor that received marketing approval on March 24, 2014, for the treatment of T2DM

Tirzepatide and breastfeeding after delivery Looking ahead: many women want to know whether they can resume tirzepatide after delivery, particularly if they plan to breastfeed